share_log

Cordlife Fails to Acquire Blood Service License From MOH

Cordlife Fails to Acquire Blood Service License From MOH

康盛人生未能从卫生部获得取得血液服务许可证
Singapore Business Review ·  09/16 00:33

It is expected to continuously impact its finances negatively.

预计将持续对其财务产生负面影响。

Cordilife Group has warned investors that its inability to resume full operations will "continuously impact its finances negatively" for the fiscal year ending 31 December 2024.

Cordilife集团已警告投资者,其无法恢复全面运营将"持续对其财务产生负面影响",截至2024年12月31日的财政年度。

In a bourse filing, Cordilife said that it is able to resume its cord blood banking service operations limitedly, with the MOH limiting the company's collection, testing, processing, and storing of new cord blood from infant donors to no more than 30 units per month until 13 January 2025.

Cordilife在证券交易所文件中表示,公司能够有限地恢复脐带血库存储服务的运营,但卫生部限制公司从婴儿供体收集、检测、处理和存储新脐带血的数量,直到2025年1月13日之前,每月不得超过30个单位。

Cordilife had earlier said that it does not intend to submit a written representation to the MOH regarding the third notice.

Cordilife此前表示,不打算向卫生部提交关于第三通知的书面材料。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发